6645 Jin Wan Lin: Announcement of Non-Compete Waiver for Directors

Jin Wan Lin approved the waiver of non-compete restrictions for new directors at its 2026 AGM. The waiver covers directors including Wu Pin-Tsung and others who hold positions at companies like Yuan Cui Data Technology and Prince Pharmaceutical. The company stated there is no material financial impact.
businessNQ 41/100出典:PR Times

📋 Article Processing Timeline

  • 📰 Published: May 23, 2026 at 06:31
  • 🔍 Collected: May 23, 2026 at 06:31 (0 min after Published)
  • 🤖 AI Analyzed: May 31, 2026 at 21:02 (206h 30m after Collected)
On May 22, 2026, Jin Wan Lin held its annual general meeting and approved the resolution to lift non-compete restrictions for new directors. The authorized directors and their concurrent positions are: Wu Pin-Tsung (Director, Yuan Cui Data Technology), Chen Hui-E (Director, Yuan Cui Data Technology; Independent Director, Beili Biotech Venture Capital), Wu Pin-Hsiang (Director, Yuan Cui Data Technology), Hung Ying-Ju (Director, Yuan Cui Data Technology), Chen Chien-Yu (Head, AEBRLOS GENOMICS INC), and Independent Director Lu Chih-Yi (Director, Prince Pharmaceutical). The waiver is effective for the duration of their tenure as directors of the company. The company stated that these concurrent positions have no material impact on its financial operations.

FAQ

Are directors of Jin Wan Lin allowed to hold concurrent positions?

Yes, the non-compete waiver was approved at the shareholders' meeting.